Three-Statement Breakdown
REVENUE UP
Revenue rose 5.2% year over year to $14.9B, and carried a 10.2% net margin.
REVENUE
+5.2%
14,911
GROSS PROFIT
—
—
NET INCOME
+0.2%
1,516
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,206 | 14,261 | 14,174 | 14,168 | 14,310 | 14,431 | 14,647 | 14,911 | +1.8% | +5.2% | |
| Research & development | (152) | (152) | (153) | (152) | (148) | (152) | (153) | (154) | +0.7% | +1.3% | |
| SG&A | (1,864) | (1,861) | (1,863) | (1,913) | (1,962) | (1,979) | (2,025) | (2,046) | +1.0% | +7.0% | |
| Operating income | 1,999 | 2,008 | 1,875 | 1,852 | 2,075 | 2,133 | 2,261 | 2,289 | +1.2% | +23.6% | |
| Interest expense | (179) | (183) | (197) | (204) | (214) | (217) | (218) | (230) | +5.5% | +12.7% | |
| Income tax | (308) | (305) | (289) | (293) | (467) | (479) | (496) | (496) | +0.0% | +69.3% | |
| Net income | 1,631 | 1,645 | 1,535 | 1,513 | 1,347 | 1,384 | 1,481 | 1,516 | +2.4% | +0.2% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-23 ↗